EX-99.3 2 dex993.htm INVESTOR PRESENTATION Investor Presentation
KBL Healthcare Acquisition Corp. II
(OTC BB: KBLH / KBLHU / KBLHW)
to acquire
Summer Infant, Inc.
Infant Health, Safety & Wellness
January 9, 2007
Exhibit 99.3


Road Show Presentation
The
attached
slide
show
was
filed
with
the
Securities
and
Exchange
Commission
(“SEC”)
as
part
of
the
amendment
to
Form
8-K
filed
by
KBL
Healthcare
Acquisition
Corp.
II
(“KBL”)
with
the
SEC
on
January
9,
2007
(“8-K
Amendment
No.
5”).
KBL
is
holding
presentations
for
certain
of
its
stockholders,
as
well
as
other
persons
who
might
be
interested
in
purchasing
KBL’s
securities,
regarding
its
acquisition
with
Summer
Infant,
Inc.
and
affiliated
companies,
as
described
in
the
September
5,
2006
8-K
filing
as
amended
by
8-K
Amendment
No.
1
filed
September
19,
2006,
8-K
Amendment
No.
2
filed
October
23,
2006,
8-K
Amendment
No.
3
filed
October
23,
2006,
8-K
Amendment
No.
4
filed
November
16,
2006
and
8-K
Amendment
No.
5.
The
attached
slide
show,
as
well
as
the
September
5,
2006
filing
as
amended
by
the
8-K
Amendments
are
being
distributed
to
attendees
of
these
presentations. 
Earlybird
Capital,
Inc.
("EBC"),
the
managing
underwriter
of
KBL's
initial
public
offering
("IPO")
consummated
in
April
2005,
is
assisting
KBL
in
these
efforts
without
charge,
other
than
the
reimbursement
of
its
out-of-pocket
expenses,
although
EBC
will
be
paid
a
cash
fee
at
the
closing
of
the
acquisition
equal
to
one
percent
(1%)
of
the
consideration
paid
in
the
acquisition.
KBL
and
its
directors
and
executive
officers
and
EBC
may
be
deemed
to
be
participants
in
the
solicitation
of
proxies
for
the
special
meeting
of
KBL
stockholders
to
be
held
to
approve
the
acquisition.
Stockholders
of
KBL
and
other
interested
persons
are
advised
to
read
KBL's
preliminary
Proxy
Statement
filed
with
the
SEC
on
October
23,
2006,
amended
preliminary
Proxy
Statement
filed
with
the
SEC
on
December
12,
2006
and,
when
available,
definitive
Proxy
Statement
in
connection
with
KBL's
solicitation
of
proxies
for
the
special
meeting
because
these
proxy
statements
will
contain
important
information.
Such
persons
can
also
read
KBL's
final
Prospectus,
dated
April
21,
2005,
for
a
description
of
the
security
holdings
of
KBL’s
officers
and
directors
and
of
EBC
and
their
respective
interests
in
the
successful
consummation
of
this
business
combination.
The
definitive
Proxy
Statement
will
be
mailed
to
stockholders
as
of
a
record
date
to
be
established
for
voting
on
the
acquisition.
Stockholders
will
also
be
able
to
obtain
a
copy
of
the
definitive
Proxy
Statement,
without
charge,
by
directing
a
request
to:
KBL
Healthcare
Acquisition
Corporation
II,
757
3rd
Ave,
New
York,
NY
10017.
The
preliminary
Proxy
Statement
and
definitive
Proxy
Statement,
once
available,
and
the
final
Prospectus
can
also
be
obtained,
without
charge,
at
the
SEC's
internet
site
(http://www.sec.gov).
2


Safe Harbor
This
presentation
may
contain
forward-looking
statements
within
the
meaning
of
the
Private
Securities
Litigation
Reform
Act
of
1995
about
KBL,
Summer
and
their
combined
business
after
completion
of
the
proposed
acquisition.
Forward-looking
statements
are
statements
that
are
not
historical
facts.
Such
forward-looking
statements,
based
upon
the
current
beliefs
and
expectations
of
KBL’s
and
Summer’s
management,
are
subject
to
risks
and
uncertainties
which
could
cause
actual
results
to
differ
from
the
forward-looking
statements.
The
following
factors,
among
others,
could
cause
actual
results
to
differ
from
those
set
forth
in
the
forward-looking
statements:
business
conditions;
changing
interpretations
of
generally
accepted
accounting
principles;
outcomes
of
government
reviews;
inquiries
and
investigations
and
related
litigation;
continued
compliance
with
government
regulations;
legislation
or
regulatory
environments;
requirements
or
changes
adversely
affecting
the
businesses
in
which
Summer
is
engaged;
fluctuations
in
customer
demand;
management
of
rapid
growth;
intensity
of
competition
from
other
providers
of
infant
health,
safety
and
wellness
products;
general
economic
conditions;
geopolitical
events
and
regulatory
changes;
as
well
as
other
relevant
risks
detailed
in
KBL’s
filing
with
the
Securities
and
Exchange
Commission,
including
its
reports
on
Form
10-QSB.
The
information
set
forth
herein
should
be
read
in
light
of
such
risks.
As
well,
some
of
Summer’s
financial
information
was
prepared
by
Summer
as
a
private
company,
in
accordance
with
U.S.
generally
accepted
accounting
principles,
and
may
not
conform
to
SEC
Regulation
S-X.
Accordingly,
such
historical
information
may
be
adjusted
and
presented
differently
in
KBL’s
proxy
statement
to
solicit
stockholder
approval
of
the
acquisition.
Neither
KBL
nor
Summer
assumes
any
obligation
to
update
the
information
contained
in
this
presentation.
3


Summer Infant is a leading designer of
innovative, branded infant health, safety and
wellness products that is well-positioned to
deliver continued strong organic growth and
to implement a focused acquisition strategy
4


Summer Investment Highlights
Large, growing industry with favorable dynamics
Proven management team with excellent track record
Emerging brand, strong relationships with major retailers
Rapid sales and EBITDA growth –
historical and projected
$0
$25,000
$50,000
$75,000
2004
Actual
2005
Actual
2006
Guidance
2007
Guidance
$0
$2,000
$4,000
$6,000
$8,000
2004
Actual
2005
Actual
2006
Guidance
2007
Guidance
Net Sales (000)
EBITDA (000)
50-53% CAGR
101-105% CAGR
High
Low
High
Low
5


The Transaction
KBLH/Summer Infant business combination pending
Acquisition agreement signed September 2006
Expected closing late February or early March 2007
Purchase price = $53.6 million + contingent payments
$20.0 million in cash
$21.9 million in KBLH common shares, locked up to April 2008 (3,916,667
shares valued at $5.59 closing price on 1/5/07)
$11.7 million in assumed debt (balance at 9/30/06)
Future contingent payments:
50% of EBITDA in excess of $4.2mm, $10.0mm, $15.0mm for 2006, 2007, 2008
(payable in cash; payments capped at $5 million total)
2.5 million KBLH common shares if post-acquisition stock price closes above
$8.50 for 20 out of 30 days prior to April 2009
Attractive valuation for rapid-growth consumer products co.
Current year multiples: 0.7-0.8x sales, 6.7-7.1x EBITDA
Prior year multiples: 1.0x sales, 10.7x EBITDA
6


Post-Transaction
Cap Table
1
Does not include contingent payments
2
Does not include underwriter purchase option and assumes no KBL stockholder conversions in
the transaction
3
Warrants calculated using the treasury method and a $5.59 KBLH stock price (closing price on
January 5, 2007)
100.0
17,059
Fully-Diluted Shares
11.4
1,942
Warrants
2,3
88.6
100.0
15,117
Common Shares
53.9
60.9
9,200
KBL Investors
2
11.7
13.2
2,000
KBL Management
23.0
25.9
3,917
Summer Shareholders
1
% Diluted
% Common
Shares (000)
Holder
7


Summer Infant
“Delivering the best for you and your baby”
Competes in large, growing infant and juvenile products
industry
Designs and markets proprietary products under the Summer
brand
Unique positioning at the high-end of the mass market based
on product innovation and new product development
Excellent mass merchant customer relationships
Emerging brand known by retailers and gaining consumer
momentum
Experienced management team and scalable infrastructure;
can support much larger company
8


Company History
2001 & 2002
Founded in autumn
Purchased name and
bouncer product
molds
Initial Sales
to
Babies “R”
Us
New Products:
Thermometers,
grooming aids,
audio/video
monitors
Net Sales:
2002 -
$6M
2003
Added retailers
Baby Depot, Buy
Buy
Baby, One Step
Ahead
New Products:
Bed
Rails, gates, bath
products
Started Summer
Europe
Net Sales:
$18M
2004
Added retailers
Target, JCPenny,
Toys “R”
Us Canada,
The Right Start,
Meijer
New Products:
Booster seats, safely
aids, further
expansion within
existing categories
Net Sales:
$21M
2005
Added Retailers: 
K-Mart, U.S.
Military PXs,
Mothercare, Tesco
New Products:
Handheld video
monitor, new gates,
new bed rails, new
baby baths, new
potty seat
2006
Added Retailers:
Sears, Sears Canada,
Wal-Mart.com,
Amazon.com,
Argos
New Products:
Soft goods, further
expansion within
existing categories
9
$36M
(guidance)
Net Sales:
Net Sales:
$52-53M


The Juvenile Products Industry
Industry is estimated to be $12 billion worldwide
Durable goods (Summer’s business) represents $4 billion
Summer’s current categories represent $1 billion
Favorable demographics drive above-average growth
Baseline demand supported by annual births (4mm/yr in US)
Sales per child increasing due to:
Increase in disposable income associated with trend towards having
children later in life
Consumer focus on quality, safety, innovation and style; spending
priority for consumers –
reinforced by media and legislation
“Grandparent effect”, second homes, mobile lifestyles
Strong retailer commitment to expand shelf space
Category is popular, profitable and repeat purchase-driven
Wal-Mart, Target, Amazon.com
have announced new initiatives
Few pure-play investment opportunities available,
particularly with significant growth
10


Differentiated Products
Strategy driven by product innovation
Internal product development and engineering team creates majority of new
products (15-20 per year)
Supplemented via opportunistic external sourcing
Products deliver incremental value to consumers
Ability to command higher price points; leads to higher revenue & margin
potential for Summer and its retail customers
Continuous product innovation reduces competitive risk
Do not compete on price
Products are unique and highly-engineered
Several products also protected by patents & trade secrets
Retailers loyal to product innovators that drive sales
Have yet to experience significant erosion due to competition
Currently hold strong/dominant share in higher-end of monitor, gate and
bath categories in mass merchant channel
Plan to replicate strategy in other categories
11


Diverse Product Mix
(as a % of 3Q YTD ‘06 Net Sales)
Monitors
Gates
Bath
Bed Rails
Medical/Infant
Health
Seats, Bouncers
& Other
35%
17%
29%
8%
6%
5%
Mix will further diversify in the future with new products
Margins tend to be strongest in highest-volume products, regardless of
category
12


Sales and Marketing
Products sold through major retailers and infant
specialty stores in the US, UK & Canada
US industry sales concentrated through 7-10 retailers
Market directly to retail chain buyers
Management & sales force have long-standing relationships with
key buyers
Significant recurring revenue
Every major customer increased purchases in 2007 over 2006
Early commitments from retailers lead to strong sales
visibility
Buying decisions primarily made in the summer for next calendar
year purchases
Purchase commitments are for one year
Very little seasonality
13


Strong Customer Relationships
Europe
North America
14


Operational Infrastructure
Scalable, low cost business model
Suburban London
European operations
HQ -
North Smithfield, RI
Electronics and QC -
Shunde
China
R&D
Approximately 70-80 worldwide
Employees
Leased facilities in Rhode Island, California,
Suburban London
Warehousing
North Smithfield, RI (new HQ in Woonsocket, RI to
be completed in Q1’07)
Headquarters
80% in Southern China
20% in Massachusetts
Manufacturing
15


Management
31 years experience: GE Healthcare,
Organogenesis
VP Operations
Paul DiCicco
20 years experience: Safety 1
st
(CFO), Staples,
KPMG Peat Marwick
Chief Financial Officer
Joseph Driscoll
Dorel, Dolly and Gibson Greetings
VP of Sales
William Basset
10 years experience: The First Years
VP Quality &
Assurance
Anthony Paolo
17 years experience: Dorel/Safety 1
st
, Mattel,
Eden Toys, Russ Berrie
VP Marketing
Lois DiMartinis
20 years industry experience: Safety 1
st
VP Research &
Development
Brian Sundberg
20 years experience: Mothercare, Dorel Juvenile
Group Europe
VP European
Operations
Rachelle Harel
20 years experience: Little Kids, Safety 1
st
,
Hasbro
EVP Product
Development
Steve Gibree
Founder; 20 years experience: Safety 1
st
, CR
Bard, & Hasbro
CEO, President,
Principal Owner
Jason Macari
Background
Title
Management
16


Post-Closing Board of Directors
EVP Product Development, Summer Infant
Steve Gibree
Former President of New Business Development, Hasbro and former
President, Hasbro -
Playskool Baby division
Robert Stebenne
Former President, Safety 1
st
; former partner, DB Capital; former board
member: The First Years, Radica, Jenny Craig
Richard Wenz
Former Professor, Harvard Business School, Co-founder, Staples;
current board member: Office Depot, Royal Ahold
Myra Hart
Former SVP and General Merchandise Manager, Toys R
Us and Babies
R
Us; former President, Baby Trend
Martin Fogelman
CEO, Summer Infant
Jason Macari
CEO, KBL Healthcare Acquisition Corp. II
Marlene Krauss, Chairperson
Background
Name
17


Multiple Growth Drivers
Summer positioned to continue to grow much
faster than the overall market
Organic growth
Increased product penetration (more products at each store)
Increased store penetration (more stores within each chain)
New products (at existing and new customers)
New mass merchant customers (new retail chains)
New channels (food and drug chains, price clubs, home centers,
additional web-based retailers)
New geographies (international expansion)
Increased operating efficiencies
Opportunistic acquisitions that provide access to
innovative products, new product categories, new
retailers, new geographies and/or new brands
18


Acquisition Opportunities
Opportunity for Summer to be consolidator
Strong balance sheet
Relationships with mass merchants
Experienced product and management team
Large and fragmented market: ~
400 infant product companies
~
5-10 are $250 million -
$1 billion
~
20-30 are $50 million-
$250 million
~ 30-50 are $10 million -
$50 million
~
300+ are under $10 million
Summer’s products currently address less than 10% of the $12 billion
market
Summer currently does not compete in the following large and growing
segments of the market:
Baby mobility -
strollers, car seats, travel systems
Baby gear -
play yards, high chairs, swings, walkers, etc.
Nursery care -
feeding & accessories, nursery needs
19


Investment Conclusion
Simple, scalable business with rapidly growing sales & profits
with good visibility
Increasing market share due to:
Innovative designs
Superior product quality
Strong value proposition
New product introductions
Strong relationships with major retailers
Experienced, proven management team
Organic and acquisition-based growth opportunities available
Enhanced financial position
20


Appendix
21


Summer Products
02090 Day & Night Color Handheld
Video Monitor First to give moms
and dads handheld portability
02170 Secure Sounds™
2.4 GHz
Digital Monitor -
Secure and
private audio transmissions
02180 Baby’s Quiet Sounds™
Video Monitor -
Leading video
monitor on the market
07160 Custom-Fit Gate -
First gate
to accommodate openings up to 12’
07030 Sure and Secure™
Top-of-
Stairs Gate with Alarm -
Audible
alarmed gate for added safety
08190 Soothing Spa and Shower
Baby Bath -
The first whirlpool
tub for baby
22


Summer Products
08160 Mother’s Touch™
Large
Comfort
Bather
-
The
perfect
alternative to bathing bigger babies
01350 Deluxe Soft Embrace™
Comfort
Bouncer-
The
next
best
thing to being cradled in mom’s arms
12020 Sure and Secure™
Double
Bedrail
-
Double
protection
and
fully assembled
08040 Newborn-to-Toddler Bath
Center
&
Shower
-
The
first
baby
bath with a clean rinse shower
04520 Deluxe Baby Essentials Kit
Everything baby needs for a
healthy start
03200 “Grow with Me”
Ear
Thermometer
-
fast
&
accurate
temperature readings with no fuss
in about 1 second
23


Competition
Fisher-Price, Safety 1
st
, The First Years,  Kids II
Small Furniture
Safety 1
st
, The First Years, Braun, Vicks
Infant Health
Evenflo, KidCo, North States, Safety 1st
Gates
Fisher-Price, Kids II, Graco, Safety 1
st
Bouncers
Safety 1
st
, The First Years, Regalo, Dex Products
Bed Rails
The First Years, Fisher-Price, Safety 1
st
, Evenflo
Baby Bath
Safety 1
st
, Bebe
Sounds, Mobi
A/V Monitors
24


Select Industry Transactions
MGA Entertainment, Inc. acquires Little Tikes (completed November 2006)
Prentice Capital Management, L.P. and D.E. Shaw Laminar Portfolios, L.L.C. purchase 42.2% of Russ Berrie
and Company, Inc. (NYSE: RUS)
(completed August 2006)
3i Group plc (LSE: III)
acquires Mayborn
Group plc (AIM: MBY)
(announced May 2006)
Royal
Philips
Electronics
(NYSE:PHG,
AEX:PHI)
acquires
AVENT
Holdings
Ltd.
(announced
May
2006)
JAKKS Pacific, Inc. (NASDAQ: JAKK)
acquires Creative Designs International, Ltd. (completed February
2006)
The
Carlyle
Group
acquires
Britax
Childcare
(completed
September
2005)
Russ Berrie
and Company, Inc. (NYSE: RUS)
acquires Kids Line, LLC (completed December 2004) 
RC2
Corporation
(NASDAQ:
RCRC),
acquires
The
First
Years,
Inc.
(NASDAQ:
KIDD)
(completed
September 2004)
Harvest
Partners
acquires
Evenflo
Company,
Inc.
(completed
August
2004)
Dorel
Industries,
Inc.
(TSE:
DII.A,
DII.B;
NASDAQ:
DIIBF)
acquires
The
Ampa
Group
(Bebe
Comfort)
(announced January 2003)
Russ Berrie
and Co., Inc. (NYSE: RUS)
acquires
Sassy, Inc. (completed September 2002)
Dorel
Industries,
Inc.
(TSE:
DII.A,
DII.B;
NASDAQ:
DIIBF)
acquires
Safety
1st,
Inc.
(NASDAQ:
SAFT)
(completed June 2000)
Playtex
Products,
Inc.
acquires
Diaper
Genie
business
(completed
January
1999)
Graco
Children’s Products, Inc. acquires Century Products Company (announced May 1998)
Evenflo
Company,
Inc.
acquires
Gerry
Baby
Products
Co.
(completed
April
1997)
Rubbermaid, Inc. acquires Graco
Children’s Products, Inc. (completed October 1996)
Mattel, Inc. (NYSE: MAT)
acquires Fisher-Price, Inc. (completed November 1993)
25


Public Market Comparables
26


Recent Transaction Multiples
27


Infant Health, Safety & Wellness
90% of products fall under healthcare classification (preventive
or diagnostic) defined by the Department of Health and Human
Services*
Majority of children’s deaths occur in first year and >80% of
children’s deaths of those under 15 years old occur before age 5
According to the NIH, Accidents are, by far, the leading cause of death
among children and adolescents. (2003)
Summer’s baby care products are subject to rigorous certification
and testing ensuring high quality standards
Food and Drug Administration (FDA)
Consumer Product Safety Commission
Juvenile Products Manufacturers Association (JPMA)
American Society for Testing Materials (ASTM)
*http://www.cms.hhs.gov/apps/hipaa2decisionsupport/CoveredEntityFlowcharts.pdf
28


KBL Healthcare Acq. Corp. II
A Specified Purpose Acquisition Company (“SPAC”)
designed to provide a profitable investment in a
health-related company
Each KBLH unit, issued at $6.00, consists of one share of
common stock and two warrants
Cash per share in trust at 9/30/06 of approximately $5.61/share
($51.7 million in trust at 9/30/06); increases with additional interest
earned
Lockup of insider shares until April 2008
29


About KBL
KBL Healthcare Acquisition Corp. I (prior SPAC)
IPO in March 1993 raised $17.5 mm gross proceeds
Merger with Concord Health Group, a long-term care/assisted living
company in August 1994
Concord sold for cash to Multicare
Companies in February 1996
Investors in KBL IPO realized 34.7 % IRR
KBL Founders Also Run KBL Healthcare Ventures
~$94mm venture capital fund
L.Ps include Novartis, Allianz, PA State Teachers Retirement
System, William Blair, Driehaus
Cap’l, Others
Representive
investments include
Spinal Concepts: sold to Abbott for $180mm in July 2003
Lumenos: sold to Wellpoint for $185mm in June 2005
Achillion Pharmaceuticals: successful IPO in October 2006
30


The KBL Team
Zachary Berk
Chairman and President
Managing Director/founder of KBL Healthcare Ventures
Founder: Prolong Pharmaceuticals, Lumenos, Transgenic Sciences (now part of
Genzyme)
Chairman & CEO: Prolong Pharmaceutiocals
B.S. and Doctorate of Optometry from Pacific University
Marlene Krauss, M.D. –
CEO, Secretary and Director
Managing Director/founder of KBL Healthcare Ventures
Founder/seed
financed:
Lumenos
(sold
to
Wellpoint
for
$185mm),
Summit
Technology
(sold to Alcon for $900mm), Candela Laser (CLZR), Cambridge Heart (CAMH)
Board Member: Cardio Focus, PneumRx, Prolong Pharmaceuticals
B.S. Cornell University, M.B.A. Harvard University( Alumni Achievement Award), M.D.
Harvard
Medical
School
(vitreoretinal
surgeon)
Michael Kaswan
COO and Director
Managing Director of KBL Healthcare Ventures
Founder: Lumenos
Board Member: Scandius
(Chairman), Remon
Medical
BS University of Virginia, MBA Harvard Business School
31